Two Kenyan Health Startups Secure USD 80 K From Villgro

By  |  December 21, 2018

A duo of Kenyan health startups comprising Maisha Meds and Turaco has been given fund grant totaling USD 80 K from Villgro Kenya. The two startups have each been awarded USD 40 K alongside incubation support.

Maisha Meds is a software platform for pharmacists and clinicians with operation in rural areas, helping them ensure the purchase of premium quality and affordable medicines. Turaco is in the offering of health loans that come with bundles of insurance to ensure that clients get access to healthcare in the event of medical emergencies.

While accessing these funds, Maisha and Turaco are as well being offered mentorship and technical expertise that will help bolster their efforts to develop their business models and scale.

Villgro Kenya is an early-stage incubator partner of the Villgro Innovations Foundation in India, supporting innovative businesses in the healthcare and life sciences sector. This isn’t the incubator’s first stride in the system, as it has also backed companies from East Africa, including Uganda’s Matibabu, ClinicPesa, and MamaOpe. Villgro Kenya also has three Kenyan health companies in their portfolio, including Flare Emergency, Enzi Healthcare, and Afya Poa.

In India, Villgro operates will early-stage social enterprises with visions to impact the lives of the underprivileged. The incubator works with companies in the health, energy and agriculture sectors, while Villgro Kenya focuses entirely on health startups to fund, mentor and give them access to a variety of networks.

Featured Image: IndianWeb2

Most Read


MPost Is Turning Phones Into Addresses In Fresh Push To Fix African E-Commerce

In the heart of Africa’s bustling tech scene, one long-standing startup remains steadfast


Headway Beyond Headlines: How Roscas Plans To Crack Mozambique’s Financially Underserved Market

While headlines trumpet a tech boom in Africa’s biggest economies, a quieter revolution


Ride-hailing Users Are Uneasy About Lagos Govt Collecting Real-Time Trip Data

A controversial issue—one that spotlights the complexities of privacy, regulation, and the evolving